Animal models of the non-motor features of Parkinson's disease.
about
What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?A progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") miceMitochondrial dysfunction and oxidative stress in Parkinson's diseaseAge-dependent effects of A53T alpha-synuclein on behavior and dopaminergic functionParkinson's disease: animal models and dopaminergic cell vulnerabilityPathogenesis of Parkinson disease--the gut-brain axis and environmental factors.Polysomnographic Features of Sleep Disturbances and REM Sleep Behavior Disorder in the Unilateral 6-OHDA Lesioned Hemiparkinsonian Rat.Unexpected improvements of spatial learning and memory abilities in chronic rotenone intoxicated mice.Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation.Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disordersExecutive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.Paraquat and psychological stressor interactions as pertains to Parkinsonian co-morbidityA pilot study on the benefit of cognitive rehabilitation in Parkinson's disease.Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis.Rodent models of Parkinson's disease: beyond the motor symptomatologyResearch on the premotor symptoms of Parkinson's disease: clinical and etiological implications.Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease.Animal models of Parkinson's disease: a gateway to therapeutics?Models of α-synuclein aggregation in Parkinson's disease.Treatment of the later stages of Parkinson's disease - pharmacological approaches now and in the future.Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.Vagal neurocircuitry and its influence on gastric motilityNon-motor features of Parkinson disease.Circadian Dysregulation in Parkinson's Disease.Basal ganglia and autism - a translational perspective.Serotonergic system in hypoxic ventilatory response in unilateral rat model of Parkinson's disease.Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP.What ARE Parkinson disease? Non-motor features transform conception of the shaking palsy.Parkinson's disease: experimental models and reality.Nonhuman Primate Models of Neurodegenerative Disorders.A Nigro-Vagal Pathway Controls Gastric Motility and Is Affected in a Rat Model of Parkinsonism.Mice lacking the Parkinson's related GPR37/PAEL receptor show non-motor behavioral phenotypes: age and gender effect.Sleep dysfunction and EEG alterations in mice overexpressing alpha-synuclein.Effect of Intrastriatal 6-OHDA Lesions on Extrastriatal Brain Structures in the Mouse.Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease.Oral supplements of aqueous extract of tomato seeds alleviate motor abnormality, oxidative impairments and neurotoxicity induced by rotenone in mice: relevance to Parkinson's disease.Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat
P2860
Q26767268-A5CE7A88-7711-4000-AD22-769009CFA113Q26859072-C06E4D3B-E747-4290-9D43-5F85B8F27033Q27014051-EE6AF73D-982B-436A-A955-4C4AD919F790Q27330366-F48B0DE2-CA86-43AF-AC4B-256B88CB9DC2Q28080503-8BD7E0EF-B889-43C5-BD9C-47451944A906Q34674177-E8E6F22B-5C9B-4431-8823-B16A18EE7F06Q34919931-4A8B96D9-D71A-4A0F-BE4C-9F7E98409A70Q35117486-8F5890C0-1223-48D9-8CDF-476BA3FC7CF7Q35416913-F643E28D-E1D2-45A6-BB65-77A62C3F7476Q36166654-7990978C-6233-4FB8-B36F-EB4AA239033DQ36200063-8389BA8F-D9B7-4A18-87C4-2FAC09F5E7ABQ36514008-94563088-5A33-4175-BC4B-8B252560AD8BQ36737558-0E2C9EB3-2CC0-4446-83F8-961AE0F8A2A9Q36896034-E79DE334-30C1-453B-B764-BCE11636FAFAQ37343565-470A7997-7BE7-4E9A-9297-477A1D300058Q37374203-9BF3F282-C583-4717-82FC-76D292E71AC2Q37591146-59403740-478B-4D4D-924E-33D50896EA06Q38155480-FFC3A897-1D81-45A4-BBAE-4A082BC60D2CQ38286574-E82BB989-758B-4458-9A51-E6FBC9017694Q38478999-23CB8FD8-6B2B-4D49-9AB9-8E9026ABED70Q38645013-F4A6D72A-D0EB-48F2-9CE2-4F49A07CD320Q38850684-E31740C9-E57F-4769-AE3C-BDECE96952B3Q39358549-D998A858-CADC-4109-B051-A6163CEE6AB8Q39438336-60ABBA61-5955-42C6-B13E-4D1D24A25D22Q39449853-D80D1DC6-6A50-4C8E-B458-D89F67C2E24EQ42293865-5F400298-FC4E-4DFB-ABCA-334A28DBD8C9Q42483926-481C0174-973B-4232-9796-91246D0599F0Q42749938-2BBD2700-29B2-4032-BE8C-AA6CC0F14F95Q47389506-B798FB3E-321D-4A66-801E-552E2142824DQ47687033-B1C39B1C-7790-4968-996C-F0795BB15336Q47799983-FD3274D7-B3E4-45C2-89E4-6153CA530AF1Q48031082-F1FEC51C-9EA3-4CEE-A133-01D39965D3C6Q48104086-277217DE-C794-40E0-ACB4-5E6016C409B9Q48274786-3E3E0DD0-95D2-407E-A707-31A50F47B27DQ50055669-4C8D9B8E-8134-49E2-9E2F-DBE839D0B461Q52771856-6A806C5F-6BB3-49C5-A853-B1C224DC79EDQ57299868-0B40E5C6-5E07-40F8-820A-C614397DB0FB
P2860
Animal models of the non-motor features of Parkinson's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Animal models of the non-motor features of Parkinson's disease.
@ast
Animal models of the non-motor features of Parkinson's disease.
@en
type
label
Animal models of the non-motor features of Parkinson's disease.
@ast
Animal models of the non-motor features of Parkinson's disease.
@en
prefLabel
Animal models of the non-motor features of Parkinson's disease.
@ast
Animal models of the non-motor features of Parkinson's disease.
@en
P2860
P1476
Animal models of the non-motor features of Parkinson's disease.
@en
P2093
Kimberly McDowell
P2860
P304
P356
10.1016/J.NBD.2011.12.040
P577
2012-01-03T00:00:00Z